Get the tools used by (smart)2 investors.
SP500 0.2%DOW 0.1%FTSE 100 -0.3%NIKKEI 0.4%OIL 0.4%GOLD 0.3%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Avg Price / Book (5y) for Regen BioPharma Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

RGBP: Regen BioPharma Inc

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune ce...

0.05 USD
Price
– USD
Fair Value
–
Upside
0.02 - 0.60
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Regen BioPharma Inc's Avg Price / Book (5y):

RGBPHLTH.USCDNAITOSPTCTFATEAGIO0.0x20.0x40.0x60.0x80.0x100.0x
Performance Summary
  • Regen BioPharma's avg price / book (5y) is -1.7x

How does Regen BioPharma's Avg Price / Book (5y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Regen BioPharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Regen BioPharma Avg Price / Book (5y) Benchmarks
NameTickerAvg Price / Book (5y)
Cytokinetics IncNASDAQGS:CYTK-7.2x
Regen BioPharma IncOTCPK:RGBP-1.7x
Curis IncNASDAQCM:CRIS-1.6x
Iteos Therapeutics IncNASDAQGM:ITOS0.5x
Neurogene IncNASDAQGM:NGNE1.0x
HealthcareSECTOR:HLTH.US2.1x
Enanta Pharmaceuticals IncNASDAQGS:ENTA2.2x
Agios PharmNASDAQGS:AGIO2.7x
Caredx IncNASDAQGM:CDNA5.5x
Fate Therapeutics IncNASDAQGM:FATE5.7x
Rhythm Pharmaceuticals IncNASDAQGM:RYTM18.0x
PTC Therapeutics IncNASDAQGS:PTCT91.8x

Metric Usage: Avg Price / Book (5y)

Hide this widget
price_to_book_avg_5y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Avg Price / Book (5y) in the valuation category include:

  • Price / Sales Growth Ratio - A heuristic used to measure the level of revenue growth relative to the Price / Sales multiple.
  • WACC - Our estimate of the weighted average cost of capital for a company.
  • Marginal Equity Risk Premium (Operating Country) - Marginal equity risk premium in the country where the company operates over the U.S. equity risk premium as estimated by professor Aswath Damodaran at NYU Stern. Source: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html.
  • Short Interest Ratio - The ratio of tradable shares being shorted to shares in the market.
View Full List

Search for metric or datapoint

Avg Price / Book (5y)

Five-year quarterly average Price / Book.

Definition of Avg Price / Book (5y)

Hide this widget
Five-year quarterly average Price / Book.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-51.6x-21.6x8.4x49.4x0200400600

The chart above depicts the distribution of avg price / book (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 2,455 companies were considered in this analysis, and 2,362 had meaningful values. The average avg price / book (5y) of companies in the sector is 2.9x with a standard deviation of 8.3x.

Regen BioPharma Inc's Avg Price / Book (5y) of -1.7x ranks in the 10.0% percentile for the sector. The following table provides additional summary stats:

Avg Price / Book (5y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,460
Included Constituents2,362
Min-58.2x
Max47.5x
Median2.3x
Mean2.9x
Standard Deviation8.3x

You can find companies with similar avg price / book (5y) using this stock screener.

All rights reserved. Terms Of Use